CN, L., ON, A. Y., NM, M., & AH, S. (2026). Fixed Dosing of Leuprolide Acetate, a GnRH Agonist, in Children with Central Precocious Puberty: A Population Pharmacokinetic Justification. Paediatric drugs, 28(3), 295. https://doi.org/10.1007/s40272-025-00733-2
Chicago Style (17th ed.) CitationCN, Lim, Al Yacoub ON, Mostafa NM, and Salem AH. "Fixed Dosing of Leuprolide Acetate, a GnRH Agonist, in Children with Central Precocious Puberty: A Population Pharmacokinetic Justification." Paediatric Drugs 28, no. 3 (2026): 295. https://doi.org/10.1007/s40272-025-00733-2.
MLA (9th ed.) CitationCN, Lim, et al. "Fixed Dosing of Leuprolide Acetate, a GnRH Agonist, in Children with Central Precocious Puberty: A Population Pharmacokinetic Justification." Paediatric Drugs, vol. 28, no. 3, 2026, p. 295, https://doi.org/10.1007/s40272-025-00733-2.